Middleton & Co Inc MA cut its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 0.4% in the second quarter, Holdings Channel.com reports. The firm owned 38,133 shares of the healthcare conglomerate’s stock after selling 150 shares during the quarter. UnitedHealth Group comprises approximately 1.4% of Middleton & Co Inc MA’s investment portfolio, making the stock its 27th biggest position. Middleton & Co Inc MA’s holdings in UnitedHealth Group were worth $9,305,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also recently added to or reduced their stakes in the stock. Norges Bank bought a new stake in UnitedHealth Group during the 4th quarter valued at about $2,343,175,000. Thoroughbred Financial Services LLC lifted its holdings in UnitedHealth Group by 25,321.4% during the 2nd quarter. Thoroughbred Financial Services LLC now owns 1,922,872 shares of the healthcare conglomerate’s stock valued at $192,287,000 after buying an additional 1,915,308 shares in the last quarter. Sanders Capital LLC lifted its holdings in UnitedHealth Group by 50.2% during the 2nd quarter. Sanders Capital LLC now owns 4,626,666 shares of the healthcare conglomerate’s stock valued at $1,255,689,000 after buying an additional 1,546,140 shares in the last quarter. FMR LLC lifted its holdings in UnitedHealth Group by 1.9% during the 4th quarter. FMR LLC now owns 64,480,003 shares of the healthcare conglomerate’s stock valued at $16,063,258,000 after buying an additional 1,232,189 shares in the last quarter. Finally, Geode Capital Management LLC lifted its holdings in UnitedHealth Group by 9.1% during the 4th quarter. Geode Capital Management LLC now owns 11,593,401 shares of the healthcare conglomerate’s stock valued at $2,882,988,000 after buying an additional 965,763 shares in the last quarter. 85.87% of the stock is owned by hedge funds and other institutional investors.
In other news, Director Richard T. Burke sold 10,000 shares of the business’s stock in a transaction dated Wednesday, May 29th. The shares were sold at an average price of $241.99, for a total value of $2,419,900.00. Following the completion of the sale, the director now owns 187,663 shares in the company, valued at approximately $45,412,569.37. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director William C. Ballard, Jr. sold 12,000 shares of the business’s stock in a transaction dated Tuesday, July 23rd. The shares were sold at an average price of $255.31, for a total transaction of $3,063,720.00. Following the completion of the sale, the director now owns 61,309 shares of the company’s stock, valued at approximately $15,652,800.79. The disclosure for this sale can be found here. In the last 90 days, insiders sold 32,000 shares of company stock valued at $7,963,620. Company insiders own 0.82% of the company’s stock.
NYSE:UNH opened at $248.08 on Monday. UnitedHealth Group Inc has a one year low of $208.07 and a one year high of $287.94. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.73 and a current ratio of 0.67. The company has a market cap of $237.63 billion, a price-to-earnings ratio of 19.26, a P/E/G ratio of 1.33 and a beta of 0.61. The firm has a 50-day simple moving average of $251.52.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 EPS for the quarter, beating the consensus estimate of $3.46 by $0.14. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The business had revenue of $60.60 billion during the quarter, compared to analyst estimates of $60.59 billion. During the same quarter in the previous year, the business posted $3.14 EPS. The company’s quarterly revenue was up 8.0% compared to the same quarter last year. Sell-side analysts expect that UnitedHealth Group Inc will post 14.82 EPS for the current fiscal year.
UNH has been the subject of a number of research analyst reports. Barclays decreased their price objective on shares of UnitedHealth Group from $290.00 to $270.00 and set an “overweight” rating for the company in a report on Wednesday, April 17th. SunTrust Banks decreased their price objective on shares of UnitedHealth Group to $300.00 and set a “buy” rating for the company in a report on Wednesday, April 17th. They noted that the move was a valuation call. UBS Group initiated coverage on shares of UnitedHealth Group in a report on Tuesday, April 23rd. They set a “neutral” rating and a $238.00 price objective for the company. Royal Bank of Canada set a $311.00 price objective on shares of UnitedHealth Group and gave the company a “buy” rating in a report on Friday, July 19th. Finally, Zacks Investment Research upgraded shares of UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 price objective for the company in a report on Monday, July 22nd. One analyst has rated the stock with a sell rating, one has given a hold rating and eighteen have assigned a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $295.06.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Article: Certificate of Deposit (CD)
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.